home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Special Statins Can Block Inflammation

  June, 1 2001 0:01
your information resource in human molecular genetics
Statin drugs, such as pravastatin and lovastatin, are a highly successful class of cholesterol-lowering medicines that prevent heart attack by reducing the amount of unhealthy fat circulating in the blood. They achieve this by blocking the liver enzyme, 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase. However, new research points to an anti-inflammatory effect of these drugs, and an article published in this month’s Nature Medicine (Vol. 7, No. 6, 01 Jun 2001) not only outlines how they suppress the inflammatory response, but also suggests that a new series of statin-like drugs could be developed with potential against autoimmune diseases such as psoriasis and theumatoid arthritis.

Gabriele Weitz-Schmidt and colleagues from Novartis Pharma AG in Switzerland, tested the ability of a range of statin drugs to bind to the integrin molecule leukocyte function antigen-1 (LFA-1) which is present on the surface of immune cells called leukocytes. LFA-1 interacts with intercellular adhesion molecule-1 (ICAM-1) to recruit leukocytes to sites of inflammation. By preventing the binding between LFA-1 and ICAM-1, statins block the inflammatory response.

The scientists went on to develop a molecule with enhanced binding affinity for the LFA-1 site but with reduced activity against HMG-CoA reductase. This compound, LFA703, almost completely blocked peritonitis in a mouse model, an effect which suggests that similarly-designed drugs may be effective in other inflammatory conditions.


Dr. Gabriele Weitz-Schmidt
Novartis Pharma AG
Preclinical Research
Tel: +41 61-324-9252
Fax: +41 61-324-9584
Email: gabriele.weitz@pharma.novartis.com

(C) Nature Medicine press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.